Celldex Therapeutics, Inc. (CLDX) has seen some recent activity in the stock market and its stock closed trading at $10.71 yesterday. Traders are starting to take interest of CLDX as the stock traded as high as $11.11 and as low as $7.35 in the previous market day.
Celldex Therapeutics, Inc. (CLDX) average trading volume is 2.22M. However, in the previous market day Celldex Therapeutics, Inc. (CLDX) traded 7,598,900 shares. The 1st support level on CLDX is $7.66. CLDX 50day moving average is $3.19 and CLDX 200day moving average is $2.48.
Celldex Therapeutics, Inc. (CLDX) recent performance has been indicated by the recent movement in CLDX stock. CLDX has performed 376.00% over the past 30 days, CLDX has performed 573.58% over the past 3 months and CLDX has shown 331.85% over the past 12 months. Celldex Therapeutics, Inc. (CLDX) has a 1 year range of $1.50 to $11.11. Celldex Therapeutics, Inc. (CLDX) is trading 614.00% from its 1 year low and -3.60% from its 1 year high. Celldex Therapeutics, Inc. (CLDX) is showing a 1.70% short float showing the sum short in the float.
CLDX has 18.94M shares outstanding and 17.72M shares in the float. Celldex Therapeutics, Inc. (CLDX) at this time has a market cap of $227.69M and income of $-46.30M. The EPS next quarter for CLDX is -0.81 and anticipated EPS net year is 14.40%. The market cap of Celldex Therapeutics, Inc. (CLDX) at $227.69M represents how many Traders own shares of CLDX and is calculated off the last price ($10.71) of CLDX and the sum of shares outstanding (18.94M) with Celldex Therapeutics, Inc. (CLDX).
Celldex Therapeutics, Inc. (CLDX) has aggregate cash (mrq) of 53.72M, aggregate cash per share (mrq) of 2.84, aggregate debt of CLDX is at 3.79M and aggregate debt/equity (mrq) is 4.53. Celldex Therapeutics, Inc. (CLDX) running cash flow (ttm) is -45.29M and CLDX leveraged free cash flow (ttm) is -23.92M.
CLDX is trading 181.49% above (bullish) its SMA20, 274.53% above (bullish) its SMA50 and 341.60% above (bullish) its SMA200.
